Exploring youth vaping in New Zealand intermediate and high schools: a mixed-methods study protocol
Abstract
BACKGROUND: Electronic nicotine delivery systems (ENDS) represent a global growing public-health concern among adolescents. In Aotearoa New Zealand (NZ), daily vaping rates have risen sharply (10.5%) among 15–17-year-olds in 2023/24. This is alarming due to nicotine’s addictive nature and its impact on adolescent brain development, mental health, and academic performance. Māori youth and those in socio-economically deprived areas are disproportionately affected, exacerbating existing health-inequities. Legislative frameworks prohibit vaping on school premises, yet ease of access remains a concern. Punitive school responses are increasingly viewed as harmful and ineffective, highlighting an urgent need for evidence-based, health-centred interventions. METHODS: This multiphase, mixed-methods study explores vaping within secondary schools on the East Coast, NZ. Phase 1 involves online surveys to collect quantitative data on vaping behaviours, targeting 1375 students to ensure sufficient statistical power. Initial qualitative data will be gathered alongside. Phase 2 employs in-depth interviews and focus groups with students (vapers/non-vapers) and staff to explore perceptions of health risks, access, and effectiveness of school responses. A rapid scoping review (RSR) will synthesise existing research on adolescent vaping in Oceanic countries, identifying behavioural patterns, legislative impacts, and gaps in the evidence base. DISCUSSION: This protocol addresses critical…
Read the paper
Related studies
- Tobacco and COPD: presenting the World Health Organization (WHO) Tobacco Knowledge Summary
- Comparative effects of e-cigarette smoking on periodontal status, salivary pH, and cotinine levels
- Association between exposure to environmental pollutants and increased oral health risks, a comprehensive review
- Influence of gestational window on offspring vascular health in rodents with in utero exposure to electronic cigarettes
- Natural products as kinase inhibitors in lung cancer: molecular mechanisms, therapeutic potential, and clinical trials
- Nicotine in electronic cigarettes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.